ASHG 2026 · Biopharma

Network Bio at ASHG 2026

Palo Alto, California

Network Bio at ASHG 2026 in Montréal: Booth 1824.

1824
exhibit booth

Explore everyone at ASHG 2026 →

OrganizationASHG 2026 Attendance
Network Bio
Palo Alto, California
Network Bio sells an AI platform trained on patient tissue and molecular data. It serves healthcare companies seeking disease detection, biomarker discovery, and personalized therapies.
Launched with $50 million in financing and what it calls the world's largest patient-tissue training dataset, a well-funded new entrant.
Launched with $50 million in financing and what it calls the world's largest patient-tissue training dataset, a well-funded new entrant.
2026-08 · source
Partnered with NVIDIA to build a cell-free RNA sequence foundation model, signaling significant compute and AI ambitions.
2026-08 · source
Published a language-model approach to cell-free RNA profiling, a research paper rather than a commercial announcement.
2025-12 · source
Source: company newsroom
Launched with $50M financing (Aug 2026)
Lead investors were not named in the announcement; this is the company's initial funding at launch. · 2026-08-19
“Network Bio Launches with $50 Million Financing and World’s Largest Patient Tissue Training Dataset”
Source: funding announcement
Currently hiring: 3 open roles
Source: careers page
Booth
Exhibiting at Booth 1824
Wed, Oct 219:45am–4:30pmThu, Oct 229:45am–1:30pmFri, Oct 239:45am–4:30pm

Explore the full ASHG 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Montréal. Leave your work email and we’ll be in touch.

Privacy

Meeting Network Bio in Montréal?

Get in-depth attendee and institution profiles and research, to plan your meetings in Montréal. Leave your work email and we’ll be in touch.

Privacy

Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction